Open AccessBeyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of the Novel Therapies for Metastatic Urothelial Carcinoma
Author(s) -
Thomas Powles,
Daniel P. Petrylak,
Jonathan E. Rosenberg
Publication year - 2021
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.21.01430
Subject(s) - medicine , metastatic urothelial carcinoma , chemotherapy , oncology , urothelial cancer , urothelial carcinoma , cancer research , cancer , bladder cancer